These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20653712)

  • 1. Monitoring fluid status at the outpatient level: the need for more precision.
    McDonald K
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S52-5. PubMed ID: 20653712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current technique of fluid status assessment.
    Frank Peacock W; Soto KM
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S45-51. PubMed ID: 20653711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of hemodynamics: an emphasis on bioimpedance cardiography.
    Rosenberg P; Yancy CW
    Curr Opin Cardiol; 2000 May; 15(3):151-5. PubMed ID: 10952420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioimpedance cardiography measurements of cardiac output and other cardiovascular parameters.
    Albert NM
    Crit Care Nurs Clin North Am; 2006 Jun; 18(2):195-202, x. PubMed ID: 16728305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of BNP and bioimpedance to drive therapy in heart failure patients.
    Di Somma S; De Berardinis B; Bongiovanni C; Marino R; Ferri E; Alfei B
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S56-61. PubMed ID: 20653713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluid overload assessment and management in heart failure patients.
    Tuy T; Peacock WF
    Semin Nephrol; 2012 Jan; 32(1):112-20. PubMed ID: 22365169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new option in measuring bioimpedance in congestive heart failure.
    Torres D; Parrinello G; Paterna S; Di Pasquale P; Torres A; Trapanese C; Licata G
    Am Heart J; 2009 Jul; 158(1):e1. PubMed ID: 19540376
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioimpedance to prevent heart failure hospitalization.
    Albert NM
    Curr Heart Fail Rep; 2006 Sep; 3(3):136-42. PubMed ID: 16914106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R; Templeton GA; Sattiraju S; Nguyen J; Sakaguchi S; Lu F; Ermis C; Milstein S; Van Heel L; Lurie KG; Benditt DG
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):488-94. PubMed ID: 19843916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient cardiovascular management utilizing impedance cardiography.
    Lasater M; Von Rueden KT
    AACN Clin Issues; 2003 May; 14(2):240-50. PubMed ID: 12819460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proactive monitoring: implications of implantable devices for future heart failure management.
    Daleiden-Burns A; Stiles P
    Crit Care Nurs Q; 2007; 30(4):321-8. PubMed ID: 17873568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhemodynamic parameters from implantable devices for heart failure risk stratification.
    Boehmer JP
    Heart Fail Clin; 2015 Apr; 11(2):191-201. PubMed ID: 25834969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring intrathoracic impedance with CRT-D devices: insight into volume status.
    Rathman L; Repoley J; Tubbs K; Small R
    Prog Cardiovasc Nurs; 2006; 21(2):97-9. PubMed ID: 16760693
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink).
    Brachmann J; Böhm M; Rybak K; Klein G; Butter C; Klemm H; Schomburg R; Siebermair J; Israel C; Sinha AM; Drexler H;
    Eur J Heart Fail; 2011 Jul; 13(7):796-804. PubMed ID: 21555324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in continuous, noninvasive hemodynamic surveillance. Impedance cardiography.
    Von Rueden KT; Turner MA
    Crit Care Nurs Clin North Am; 1999 Mar; 11(1):63-75. PubMed ID: 10373824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the "5B" approach.
    Ronco C; Kaushik M; Valle R; Aspromonte N; Peacock WF
    Semin Nephrol; 2012 Jan; 32(1):129-41. PubMed ID: 22365171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathoracic impedance monitoring for early detection of impending heart failure decompensation.
    Abraham WT
    Congest Heart Fail; 2007; 13(2):113-5. PubMed ID: 17392616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Techniques for the assessment of volume status in patients with end stage renal disease.
    Rosner MH; Ronco C
    Semin Dial; 2014; 27(6):538-41. PubMed ID: 25039904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.